Document |
Document Title |
WO/2000/040678A1 |
A process for the preparation of a triazine derivative, the reaction products of said process, lubricating oil compositions, fuel compositions and additive concentrates containing such reaction products, and use of the reaction products ...
|
WO/2000/040567A1 |
The invention relates to a process for the preparation of melamine from urea comprising the steps of: (a) introducing urea melt and hot ammonia gas into a melamine reactor having a pressure within the range 50-150 bar and a temperature w...
|
WO/2000/040566A1 |
The invention relates to a process for the separation of a component from a gaseous medium by crystallization comprising injecting a gaseous medium containing the component to be separated into a cooling liquid in a crystallizer to form ...
|
WO/2000/039107A1 |
The invention relates to a method for purifying melamine in which impure melamine is heated to a temperature range above 325 °C but lower than the melting point of melamine which depends on the prevailing ammonia pressure. In addition, ...
|
WO/2000/037567A1 |
The invention relates to compounds which in the free acid form have the formula (I) in which the substituents have the meanings given in the description. Said compounds are extremely well suited for use as ink-jet inks.
|
WO/2000/037434A1 |
Amide derivatives represented by general formula (I), which have an activity against $i(Helicobacter pylori) and are useful as the active ingredient of drugs, pharmaceutically acceptable salts thereof or solvates or hydrates of the same,...
|
WO/2000/037449A1 |
The reaction product of: (i) a polyalkenyl derivative of an ethylenically unsaturated carboxylic reagent and (ii) a compound of formula (I), wherein R is a linear alkylene group having at least 2 carbon atoms, a branched alkylene group h...
|
WO/2000/037450A1 |
The invention relates to carboxylic acid derivatives of formula (I), in which the substituents have the following meanings: R?1¿ is tetrazol or a group (a); W and Z, can be identical or different and are nitrogen or methine, provided th...
|
WO/2000/037084A1 |
Disclosed herein is a method of treating therapeutically, or metaphylactically infected animals susceptible to, or infected animal suffering from parasitic neurologic or abortigenic diseases such as Sarcocystidiae or Toxoplasmosis that a...
|
WO/2000/037063A2 |
Disclosed herein are methods of treating therapeutically, or metaphylactically infected animals susceptible to, or infected animal suffering from parasitic neurologic or abortigenic diseases such as Sarcocystidiae or Toxoplasmosis that a...
|
WO/2000/037064A2 |
Disclosed herein are methods of treating therapeutically, or metaphylactically infected animals susceptible to, or infected animal suffering from parasitic neurologic or abortigenic diseases due to $i(Sarcocystis), $i(Neospora) or $i(Tox...
|
WO/2000/035885A1 |
Hydrazine derivatives of formula (I) wherein W represents O, S, CO, NR?5¿, (CR?3¿R?4¿)¿m?, or CR?11¿; X represents CO, NR?6¿, (CH¿2?)¿n?, CR?12¿ or CHR?13¿; Y represents CO, NR?7¿, (CH¿2?)¿p?, or CHR?14¿; Z represents CO, C...
|
WO/2000/035857A1 |
The present invention describes the preparation of multifunctional imine-esters and their application as novel crosslinkers for surface coatings. The imine-esters are prepared by reacting a di- or tri-aldehyde with an $g(a)-aminoester su...
|
WO/2000/036025A1 |
Compounds of general formula (I) wherein R¿1? represents hydrogen or a C¿1?-C¿4?-alkyl group, X represents the radical of aliphatic, cyclic or aromatic diamines and Y represents hydrogen or an alkali metal, and a process for their pre...
|
WO/2000/034215A1 |
Disclosed is a method of making an $g(a)-chloro-$g(a),$g(a)-difluoro aromatic compound. An $g(a),$g(a),$g(a)-trichloro aromatic compound having general formula (a), (b), (c), (d) or (e) where Y is C or N, R is halogen, R', amino, NHR', N...
|
WO/2000/034234A1 |
The present invention pertains to the field of medicine, more precisely to that of pharmacology, essentially relates to biologically active synthetic compounds of the heterocyclic series and is mainly intended for use in medical practice...
|
WO/2000/032589A1 |
The present invention provides eletriptan hydrobromide monohydrate of formula (I) together with processes for preparing, uses of, and compositions containing, said monohydrate.
|
WO/2000/032573A1 |
The present invention relates to a meta-nitro phenol derivative of formula (I) wherein X is halogen, cyano, nitro, C1-6haloalkyl or C1-6haloalkoxy; Y is hydrogen, halogen, cyano, nitro, C1-6haloalkyl or C1-6haloalkoxy; Z is oxygen, sulfu...
|
WO/2000/032580A2 |
The invention relates to novel substituted 1,3,5-triazines of general formula (I), in which A represents CHR?3¿R?4¿ or represents C¿1?-halogenoalkyl-substituted C¿3?-C¿6?-cycloalkyl, C¿3?-C¿6?-alkinyl or C¿1?-C¿4?-cyanoalkyl, wh...
|
WO/2000/031036A1 |
Novel naphthalene derivatives represented by general formula (1), which exhibit an excellent fibrinolysis accelerating effect and are useful as orally administrable antithrombotic or thrombolytic agents.
|
WO/2000/029392A1 |
It has been now surprisingly discovered after extensive research that 2-halo-4,6-bisaryl-1,3,5-triazine can be prepared with unprecedented selectivity, efficiency, mild conditions, and in high yield by the reaction of cyanuric halide wit...
|
WO/2000/029404A1 |
Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives represented by general formula [I]; agricultural/horticultural bactericides containing the same as the active ingredient; and intermediates in producing the same represented...
|
WO/2000/029393A1 |
The invention relates to a method for producing pure melamine. According to this method, the melamine melt, which is produced from urea in a high-pressure process, is cooled and ammonia is added until it reaches a temperature of approxim...
|
WO/2000/027828A2 |
This invention concerns the use of the compounds of formula (I), the $i(N)-oxides, the pharmaceutically acceptable addition salts, quaternary amines and the stereochemically isomeric forms thereof, wherein -a?1¿=a?2¿-a?3¿=a?4¿- forms...
|
WO/2000/027337A2 |
The invention concerns a method for improving the stability of at least a 1,3,5-triazine derivative to UV radiation in the absence of any dibenzoylmethane derivative. The invention is characterised in that it consists in associating with...
|
WO/2000/027829A1 |
The present invention relates to a method for preparing tris-substituted alkoxycarbonylamino-1,3,5-triazine compounds, which involves reacting an amino-1,3,5-triazine compound such as melamine, for example, in the presence of excess amou...
|
WO/2000/026315A1 |
The present invention provides a curable coating composition that includes at least three components. The coating composition includes a component (a) that includes one or both of a compound (a)(1) having at least one carbamate group or ...
|
WO/2000/026313A1 |
The present invention provides a curable coating composition that includes at least three components. The coating composition includes a component (a) having at least one carbamate group or urea group and having a lactone or hydroxy carb...
|
WO/2000/026314A1 |
The present invention provides a curable coating composition that includes at least three components. The coating composition includes a component (a) that includes one or both of a compound (a) (1) having at least one carbamate group or...
|
WO/2000/021938A1 |
The invention relates to substituted formylaminotriazines of general formula (I), wherein A, R and Z have the meanings given in the description. The invention also relates to methods for producing the novel substituted formylaminotriazin...
|
WO/2000/021940A1 |
A method for the production of melamine from urea via a high-pressure non-catalytic process in which molten urea is reacted to produce melamine, carbon dioxide, and ammonia, the by-product gases are separated from the melamine melt, and ...
|
WO/2000/021939A1 |
The invention provides 2-(para-sulfophenyl)amino-1,3,5-triazine derivative of formula (I) and the salt of alkali metal thereof, in which R¿1? is chloro or fluoro; R¿2? is $g(a)- or $g(b)-naphthyl amino group, or $g(a)- or $g(b)-naphthy...
|
WO/2000/018724A1 |
The invention relates to substituted aryl and heteroaryl (R)-Chiral Halogenated 1-Substitutedamino-(n+1)-Alkanol compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, ...
|
WO/2000/018721A1 |
The invention relates to substituted polycyclic aryl and heteroaryl $i(tertiary)-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions an...
|
WO/2000/018759A1 |
Phenylalanine derivatives of formula (1) are described in which: Ar?1¿ is an aromatic or heteroaromatic group; L?1¿ is a linker atom or group; R is a carboxylic acid or a derivative thereof; Ar?2¿ is an optionally substituted aromatic...
|
WO/2000/017171A1 |
A process which enables easy and inexpensive preparation of alkylenebismelamine derivatives usable as components for forming resin materials including aminoplasts, and flame-retardant materials. Specifically, a process for the preparatio...
|
WO/2000/016766A1 |
A medical composition containing, as an active constituent, a nitroetheneamine derivative represented by formula (I) wherein R?1¿ is a hydrogen atom, an optionally substituted alkyl, alkenyl, alkinyl, cycloalkyl, cycloalkenyl, aryl or h...
|
WO/2000/015619A1 |
The invention relates to a method for producing a stabilized aqueous alkali metal-2-hydroxy-4,6-dichloro-s-triazine (AHDT) solution in which a solution is provided at a temperature ranging from 5 to 40 °C. Said solution contains either ...
|
WO/2000/014077A1 |
Provided is a new process for the preparation of compositions containing at least one triazine ultraviolet light absorber.
|
WO/2000/014076A1 |
The invention relates to a process of making substituted triazine compounds and mixtures of substituted triazine compounds. The invention particularly relates to a process of making mono- and bis-(2-hydroxy-4-alkoxyphenyl) substituted tr...
|
WO/2000/014075A1 |
The invention relates to a novel process for making 2-(2-hydroxy-4-alkoxyphenyl)-4,6-bisaryl-1,3,5-triazine and 2-(2,4-dialkoxyphenyl)-4,6-bisaryl-1,3,5-triazine compounds directly from 2-chloro-4,6-bisaryl-1,3,5-triazine compounds with ...
|
WO/2000/014074A1 |
The invention provides new processes for preparing compositions containing at least one triazine compound, including new compounds for use in these processes to form the compositions and the new compositions that are formed.
|
WO/2000/012084A1 |
The present invention relates to novel geometrically restricted 2-indolinones and physiologically acceptable salts thereof which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treat...
|
WO/2000/012609A1 |
Flame retardant blends comprising at least one polyestercarbonate, at least one addition polymer such as a styrene-acrylonitrile or ABS copolymer, and at least one phosphoryl flame retardant have high temperature stability properties sup...
|
WO/2000/009477A1 |
The invention relates to unsaturated oligophenol cyanates of the general formula (I) [A-]¿n?[B-A-]¿x?B[-A]¿m?, in which A is a group of formula (II) and B is a group of formula (III), where R?1¿, R?2¿ and R?3¿ are each hydrogen or ...
|
WO/2000/009489A1 |
The invention relates to new carboxylic acid derivatives of the formula (I), where the substituents have the meaning given in the description, their production and their use as endothelin-receptor antagonists.
|
WO/2000/002868A1 |
Compounds of formula (I) or their salts are suitable for producing active agents from the class of aminotriazines of formula (IV), for example herbicide agents. Said compounds of formula (I) are produced by chlorinating compounds of form...
|
WO/2000/002865A1 |
This invention relates to compounds of formula (1) wherein B is optionally substituted aryl; R?1¿ and R?2¿ are the same or different and are independently selected from hydrogen or C¿1-3? alkyl; n is 1 or 2, preferably n is 1; m is 0 ...
|
WO/2000/002869A1 |
Salt of a 1,3,5-triazine compound with polyphosphoric acid with a virtually linear structure, with the number average degree of condensation n being higher than 20, the content of the 1,3,5-triazine compound being higher than 1.1 mole pe...
|
WO/2000/000480A1 |
The invention relates to substituted 2,4-diamino-1,3,5-triazines of general formula (I) and to the salts thereof. The invention also relates to methods for the production of the substituted triazines and to their use as herbicides and pl...
|